Literature DB >> 1939655

In vitro growth rate of placental fibroblasts is developmentally regulated.

M E Fant1.   

Abstract

Placental cells of mesenchymal origin were used to study the regulation of fetal growth at the cellular level. A significant difference in the in vitro growth rates of placental fibroblasts was observed as a function of gestational age. Cells derived from 10-19-wk placentae exhibited proliferative rates two to three times greater than cells derived from 7-9-wk placentae (16-30 h vs. 30-60 h, P less than 0.001). The proliferation rate remained stable throughout multiple passages in culture. Additionally, these two groups of cell strains exhibited marked differences in their responsiveness to mitogenic stimuli. Using maximal effective concentrations, insulin-like growth factor I interacted synergistically with epidermal growth factor and fibroblast growth factor to stimulate DNA synthesis in cells derived from 10-19-wk placentae. By contrast, the interaction of insulin-like growth factor 1 with epidermal growth factor and fibroblast growth factor exhibited significantly less synergy in 7-9-wk cells. These findings argue that the accelerated growth rate of human fetal cells results primarily from developmental events intrinsic to the cells and is associated with enhanced responsiveness to the mitogenic action of peptide growth factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939655      PMCID: PMC295706          DOI: 10.1172/JCI115486

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Effects of prolonged quiescence on neuclei and chromatin of WI-38 fibroblasts.

Authors:  M Rossini; J C Lin; R Baserga
Journal:  J Cell Physiol       Date:  1976-05       Impact factor: 6.384

2.  Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells.

Authors:  B Pfeifle; H Boeder; H Ditschuneit
Journal:  Endocrinology       Date:  1987-06       Impact factor: 4.736

3.  Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.

Authors:  E M Rutanen; F Pekonen; T Mäkinen
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

4.  An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.

Authors:  R G Elgin; W H Busby; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae.

Authors:  H J Kliman; J E Nestler; E Sermasi; J M Sanger; J F Strauss
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

6.  Characterization of the binding of multiplication-stimulating activity to a receptor for growth polypeptides in chick embryo fibroblasts.

Authors:  M M Rechler; J M Podskalny; S P Nissley
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

7.  Production of insulin-like growth factor binding protein(s) (IGF-BPs) by human placenta: variation with gestational age.

Authors:  M Fant; H Munro; A C Moses
Journal:  Placenta       Date:  1988 Jul-Aug       Impact factor: 3.481

8.  Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth.

Authors:  A S Goustin; C Betsholtz; S Pfeifer-Ohlsson; H Persson; J Rydnert; M Bywater; G Holmgren; C H Heldin; B Westermark; R Ohlsson
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

9.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 10.  Oncogenes in development.

Authors:  E D Adamson
Journal:  Development       Date:  1987-04       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.